drugset / Trial / NCT00296530
Study Of Patients With Allergic Rhinitis And Asthma
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will last up to 6 weeks. Subjects will visit the clinic up to 5 times. Certain clinic visits will include a physical examination, medical history review, and lung function tests. All study related medications and medical examinations will be provided at no cost to the subject. The drugs used in this study are approved for the age group under study.
Timeline
- Start
- 2005-09
- Primary completion
- 2007-07
- Completion
- 2007-07
Publications
- Background This study has not been published in the scientific literature.
- Katial RK, Oppenheimer JJ, Ostrom NK, Mosnaim GS, Yancey SW, Waitkus-Edwards KR, Prillaman BA, Ortega HG. Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis. Allergy Asthma Proc. 2010 Jan-Feb;31(1):68-75. doi: 10.2500/aap.2010.31.3306.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone propionate | Other / unclassified | 200 ug | Intranasal |
| Subject | Montelukast | Other / unclassified | 10 mg | — |
| Subject | fluticasone propionate/salmeterol | Unknown | — | — |